MolNFT v1 · #114800 · protein
Fragment-based drug discovery targeting inhibitor of apoptosis proteins: compound 2
5C0L · E3 ubiquitin-protein ligase xiap: “Fragment-based drug discovery targeting inhibitor of apoptosis proteins: compound 2”. X-ray diffraction, 2 ligands (4WJ, ZN). MolNFT v1 #114800 on GenesisL1: 3D structure, binding sites and pockets…
- PDB
- 5C0L
- Type
- protein
- Length
- 106 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- E3 ubiquitin-protein ligase xiap
- EC
- 6.3.2.-
- UniProt
- P98170
- Ligands
- 4WJ, ZN
Structure
x-ray diffraction · 1 distinct chain · 46% helix, 8% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | E3 ubiquitin-protein ligase xiap (EC 6.3.2.-) | protein | 106 | 46% helix, 8% strand | P98170 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 5C0L · Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 2 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P98170
- Elsewhere: RCSB PDB 5C0L · PDBe 5C0L · UniProt P98170
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.